Ipsen Pharma is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. Our commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen sells more than 20 drugs in over 115 countries (USA & Canada, Russia, Korea, China, ...). We have about 5,100 employees worldwide. In Ipsen Pharma Vietnam, we has a well-established Consumer Healthcare business since 1996, focus on the neurological and digestive products.